Advanced Medical Solutions Group plc
AMS.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -1.08 | -1.29 | 1.69 | 0.40 |
| FCF Yield | 2.99% | 0.56% | 3.05% | 3.28% |
| EV / EBITDA | 16.61 | 12.68 | 13.97 | 21.11 |
| Quality | ||||
| ROIC | 2.13% | 5.25% | 7.52% | 7.86% |
| Gross Margin | 46.62% | 55.57% | 55.19% | 51.67% |
| Cash Conversion Ratio | 2.36 | 0.78 | 1.33 | 1.74 |
| Growth | ||||
| Revenue 3-Year CAGR | 12.61% | 5.14% | 12.73% | 1.99% |
| Free Cash Flow Growth | 407.69% | -85.42% | -28.52% | 51.62% |
| Safety | ||||
| Net Debt / EBITDA | 2.34 | -1.63 | -2.08 | -2.00 |
| Interest Coverage | 2.94 | 49.17 | 39.01 | 20.95 |
| Efficiency | ||||
| Inventory Turnover | 1.54 | 1.56 | 2.00 | 2.72 |
| Cash Conversion Cycle | 202.71 | 258.58 | 204.11 | 170.93 |